Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 48.0 | 65 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 41.0 | 59 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 27.0 | 69 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 56.5 | 44 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 59.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 61.0 | 52 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 82.0 | 47 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 81.0 | 57 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 65.0 | 52 | |
N2759 | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 60.5 | 50 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 61.0 | 53 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 68.0 | 53 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 72.0 | 49 | |
N2586 | TNF-a | 100 | ng/mL | 1 | PDGF-BB | 69.0 | 54 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 22.0 | 52 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 25.0 | 47 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 20.0 | 59 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 27.0 | 52 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 20.0 | 51 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 23.0 | 41 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 23.0 | 55 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 28.0 | 54 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 51.0 | 51 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 50.0 | 33 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 55.0 | 43 |